Intervention and comparator intervention | Sex [female %] | Age [mean years (CI/SD/range)] | Comedications/Cointerventions | Comorbidities | |
Barczynski 2012 | I: total thyroidectomy | 89 | 46.2 (CI 43.5 to 48.9) | Antithyroid drugs/beta blockers | ‐ |
C: bilateral subtotal thyroidectomy | 89 | 45.5 (CI 43.1 to 47.9) | |||
Witte 2000 | I: total thyroidectomy | 82 | 38 (19 to 68) | Antithyroid drugs/beta blockers (40%), thyroid hormone substitution (40.7%) | ‐ |
C1: bilateral subtotal thyroidectomy | 86 | 35.5 (12 to 73) | |||
C2: Dunhill procedure | 82 | 41 (17 to 66) | |||
Jarhult 2005 | I: total thyroidectomy | 95 | 44 (21 to 62) | Antithyroid drugs for at least 3 months preoperatively Postoperative thyroxine supplementation 5 participants in each group received cortisone to decrease the activity of the EO |
‐ |
C: subtotal thyroidectomy | 86 | 42 (24 to 69) | |||
Chi 2005 | I: bilateral subtotal thyroidectomy | 84 | 33.3 (SD 0.73) | Propylthiouracil/methimazole | ‐ |
C: Dunhill procedure | 87 | 34.5 (SD 0.93) | |||
Muller 2001 | I: bilateral subtotal thyroidectomy | ‐ | 30.8 (14 to 78) | Antithyroid medication | ‐ |
C: Dunhill procedure | ‐ | 30.8 (14 to 78) | |||
‐ denotes not reported C: comparator; CI: confidence interval; EO: endocrine ophthalmopathy; I: intervention; SD: standard deviation |